Engineers Gate Manager LP Sangamo Therapeutics, Inc Transaction History

Engineers Gate Manager LP

$7.46 Billion
Q2 2025

A detailed history of Engineers Gate Manager LP transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 87,425 shares of SGMO stock, worth $59,449. This represents 0.0% of its overall portfolio holdings.

Number of Shares

87,425

Previous 43,347 101.69%

Holding current value

$59,449

Previous $28,000 67.86%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$0.43 - $0.81 $18,953 - $35,703	44,078 Added 101.69%	87,425 $47,000
Q1 2025 May 15, 2025	SELL	$0.66 - $1.37 $7,650 - $15,881	-11,592 Reduced 21.1%	43,347 $28,000
Q4 2024 Feb 14, 2025	BUY	$0.78 - $2.87 $7,409 - $27,262	9,499 Added 20.9%	54,939 $56,000
Q3 2024 Nov 14, 2024	SELL	$0.32 - $1.1 $3,556 - $12,226	-11,115 Reduced 19.65%	45,440 $39,000
Q2 2024 Aug 14, 2024	BUY	$0.36 - $0.65 $582 - $1,051	1,618 Added 2.95%	56,555 $20,000
Q1 2024 May 15, 2024	SELL	$0.42 - $1.38 $679 - $2,232	-1,618 Reduced 2.86%	54,937 $36,000
Q4 2023 Feb 14, 2024	BUY	$0.3 - $0.63 $5,230 - $10,984	17,436 Added 44.57%	56,555 $30,000
Q3 2023 Nov 14, 2023	SELL	$0.58 - $1.47 $1,735 - $4,398	-2,992 Reduced 7.11%	39,119 $23,000
Q2 2023 Aug 14, 2023	BUY	$1.11 - $1.74 $46,743 - $73,273	42,111 New	42,111 $54,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $69,558 - $104,093	16,290 New	16,290 $80,000
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.21 $165,968 - $314,226	-50,600 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.23 - $7.82 $117,675 - $175,950	22,500 Added 80.07%	50,600 $294,000
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $27,760 - $41,773	-3,808 Reduced 11.93%	28,100 $211,000
Q3 2021 Nov 15, 2021	SELL	$9.01 - $12.01 $184,849 - $246,397	-20,516 Reduced 39.13%	31,908 $287,000
Q2 2021 Aug 16, 2021	BUY	$10.17 - $12.64 $296,394 - $368,380	29,144 Added 125.19%	52,424 $628,000
Q1 2021 May 17, 2021	BUY	$10.88 - $17.05 $253,286 - $396,924	23,280 New	23,280 $292,000
Q4 2020 Feb 16, 2021	SELL	$9.23 - $18.18 $856,959 - $1.69 Million	-92,845 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.38 - $12.48 $125,888 - $167,494	13,421 Added 16.9%	92,845 $877,000
Q2 2020 Aug 17, 2020	BUY	$6.21 - $11.83 $493,223 - $939,585	79,424 New	79,424 $712,000

Others Institutions Holding SGMO

# of Institutions

126

Shares Held

51.2M

Call Options Held

1.12M

Put Options Held

789K

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $106M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Sangamo Therapeutics, Inc Transaction History